SUBSCRIBERS
Lonza in joint venture to develop biotherapeutic products
Published Wed, Apr 3, 2019 · 09:50 PM
Singapore
SWISS biotech company Lonza has entered into an equal joint venture (JV) with Danish bioscience company Chr Hansen Holding to develop live biotherapeutic products (LBP) for pharma and biotech customers.
The phased investment of about 90 mill…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
China’s Noah to hire 50 to 100 wealth managers in Hong Kong, Singapore
Australian inflation boosts case for higher-for-longer rates
Gold edges down as Middle East worries ebb
Tesla could start selling Optimus robots by the end of next year, Musk says
Singapore stocks climb at Wednesday’s open; STI up 0.4%
China knockoff raid jolts a global throng of fake-fashion influencers